Sensitivity of biofilms of vaccine and freshly isolated Bordetella pertussis strains to antibiotics
Open Access
- 20 January 2021
- journal article
- research article
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 97 (6) , 529-534
Abstract
Aim. To study the sensitivity of biofilms of vaccine and freshly isolated strains of Bordetella pertussis to antibiotics.Materials and methods. Vaccine and freshly isolated strains of B. pertussis were used. Cultures of strains grown on dense nutrient medium were used as inoculate for biofilms production. The intensity of biofilm formation in round-bottomed polystyrene 96-well plates was estimated by staining with 0.1% gentian-violet solution. The following antibiotics were used in experiments: penicillins (ampicillin), cephalosporins (ceftriaxone), aminoglycosides (gentamicin), macrolides (erythromycin).Results. The highest resistance to antibiotics was demonstrated by the vaccine strain No. 305 and freshly isolated strain No. 211, sensitive only to erythromycin. Vaccine strain No. 703 was sensitive to gentamicin and ampicillin and showed resistance to erythromycin and ceftriaxone. Vaccine strain No. 475 was sensitive to all tested antibiotics. The Tohama 1 strain was resistant to ampicillin and sensitive to other antibiotics. Freshly isolated strains No. 178 and No. 162 were resistant to ceftriaxone and sensitive to gentamicin, erythromycin and penicillin. Minimal inhibitory concentrations of tested antibiotics ranged from 0.2 μg/ml to 5.0 μg/ml.Conclusion. These data indicate the heterogeneity of vaccine and freshly isolated strains of B. pertussis in sensitivity to antibiotics. The greatest activity was shown by erythromycin, which suppressed the growth of biofilms of 6 out of 7 strains. The least effective was ceftriaxone, which suppressed the growth of biofilms of only 2 strains.Keywords
This publication has 9 references indexed in Scilit:
- The biofilm formation of freshly isolated and vaccine strains of Bordetella pertussis of different serotypesJournal of microbiology, epidemiology and immunobiology, 2019
- In vitro activity and clinical efficacy of macrolides, cefoperazone-sulbactam and piperacillin/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates: A single-centre study in Zhejiang Province, ChinaJournal of Global Antimicrobial Resistance, 2019
- Pertussis vaccines and protective immunityCurrent Opinion in Immunology, 2019
- Molecular Epidemiology of Bordetella pertussis2019
- Immunogenicity and protective potential of Bordetella pertussis biofilm and its associated antigens in a murine modelCellular Immunology, 2019
- Antimicrobial susceptibility testing of Finnish Bordetella pertussis isolates collected during 2006–2017Journal of Global Antimicrobial Resistance, 2018
- Biofilm forming potential and antimicrobial susceptibility of newly emerged Western Australian Bordetella pertussis clinical isolatesBiofouling, 2016
- Pertussis: Microbiology, Disease, Treatment, and PreventionClinical Microbiology Reviews, 2016
- Bordetellabiofilms: a lifestyle leading to persistent infectionsPathogens and Disease, 2015